US BANCORP \DE\ - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 60 filers reported holding ONCOCYTE CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$115
-35.0%
5000.0%0.00%
Q1 2023$177
+9.9%
5000.0%0.00%
Q4 2022$1615000.0%0.00%
Q3 2022$05000.0%0.00%
Q2 2022$0
-100.0%
5000.0%0.00%
Q1 2022$1,0000.0%5000.0%0.00%
Q4 2021$1,000
-50.0%
5000.0%0.00%
Q3 2021$2,000
-33.3%
5000.0%0.00%
Q2 2021$3,0000.0%5000.0%0.00%
Q1 2021$3,000
+200.0%
5000.0%0.00%
Q4 2020$1,000
-80.0%
500
-86.7%
0.00%
Q3 2020$5,0003,7590.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 23,353,697$17,048,0001.30%
AWM Investment Company, Inc. 7,746,557$5,655,0000.86%
PURA VIDA INVESTMENTS, LLC 18,056,274$13,181,0000.76%
Defender Capital, LLC. 2,551,980$1,883,0000.74%
Penbrook Management LLC 563,350$411,0000.35%
ACT CAPITAL MANAGEMENT, LLC 330,000$241,0000.33%
CALIBER WEALTH MANAGEMENT, LLC 75,120$55,0000.04%
Fort Sheridan Advisors LLC 135,000$99,0000.03%
Orbimed Advisors 1,882,768$1,374,0000.03%
WEALTH EFFECTS LLC 51,000$37,0000.02%
View complete list of ONCOCYTE CORP shareholders